Der amerikanische Pharma-Konzern Pfizer hat am Dienstag vor der US-Börseneröffnung die Zahlen für das erste Quartal 2025 vorgelegt. Diese sind…
Der amerikanische Pharma-Konzern Pfizer hat am Dienstag vor der US-Börseneröffnung die Zahlen für das erste Quartal 2025 vorgelegt. Diese sind…
U.S. drugmaker Pfizer reported first-quarter profit above Wall Street estimates on Tuesday, helped by cots cuts and better-than-expected sales of…
Pfizer Inc (NYSE:PFE, ETR:PFE) reported mixed results for the first quarter, including an earnings beat but revenue below expectations. Revenue…
Pfizer Inc (NYSE:PFE, ETR:PFE) reported mixed results for the first quarter, including an earnings beat but revenue below expectations. Revenue…
StoneCo, Carriage Services, Associated Banc-Corp and Pfizer have been highlighted in this Screen of The Week article.…
Dow, S&P 500, and Nasdaq 100 futures are rising in premarket trading ahead of an expected auto tariffs announcement by…
US stock market indexes are set for another mixed session on Tuesday, as a busy week for earnings continues, with numbers…
Many income investors would love to have a low-maintenance portfolio that doesnt require constant attention. Theyd prefer to buy great…
In many ways, the pandemic is becoming a faded memory. With that, a major pandemic star -- biotech Moderna (NASDAQ:…
Getting dizzy from the stock markets gyrations? Join the club. The major market indexes are behaving like a frantic yo-yo,…
• Tariff headlines, ‘Mag 7’ earnings, U.S. jobs report, and PCE inflation data will be in focus this week.…
…
Charlotte (www.aktiencheck.de) - Rating-Update:
Die Analysten von BofA Securities stufen die Aktie von Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol: PFE,…
Pfizers non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the…
Market uncertainty has become the defining characteristic of the 2025 investment landscape. Thanks to volatile trade policies, persistent inflation concerns,…
Having significant capital in the bank when investing in equities is helpful, but is by no means necessary. Even with…
In the closing of the recent trading day, Pfizer (PFE) stood at $22.36, denoting a -0.78% change from the preceding…
Passive income is essential in retirement, but building a dependable stream isnt easy. Fortunately, top-tier dividend stocks can do the…
…
The anti-obesity drug market has the potential to be massive, with multiple analysts projecting it may reach at least $100…
PFEs non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the…
Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. The biotechs shares closed the day nearly 3%…
Every cloud has a silver lining. Sometimes, they have two. Thats the case with many stocks in the current market…
The S&P 500 has dropped 10% or more nine times since 2010, not including the current sell-off. However, the index…
Its been a tough start to 2025 for investors amid concerns regarding the strength of the U.S. economy and uncertainties…
Although it isnt the largest therapeutic area in the pharmaceutical industry, the market for weight loss therapies has caught fire…
Factors driving the market include rising disease prevalence, innovative therapies, and gene-based treatment breakthroughs. Key players like H Lundbeck and…
Pfizer (PFE) closed the most recent trading day at $22.15, moving +0.48% from the previous trading session.…
The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu vaccines…
…
…
On Tuesday, investors continued to snap up shares of big pharmaceutical company Pfizer (NYSE: PFE). Somewhat counterintuitively, this weeks rise…
…
New York (www.aktiencheck.de) - Pfizer-Aktienanalyse von Morgan Stanley:
Entwicklung von Danuglipron eingestellt
Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol: PFE, NYSE-Symbol: PFE)…
Pfizer (NYSE: PFE) recently reminded investors how risky the drug-development business can be. On April 14, the company told investors…
Kulmbach (www.aktiencheck.de) - Pfizer-Aktienanalyse von "Der Aktionär":
Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Pfizer Inc. (ISIN: US7170811035,…
Der DAX ist stark in die neue Woche gestartet. Gestern schloss er 2,85 Prozent höher bei 20.954 Punkten. Die Märkte…
Trotz negativer News und der anhaltenden Unsicherheit aufgrund möglicher Zelle im Medizinbereich hat die Aktie des Pharmakonzerns Pfizer am Montag…
NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Pfizer mit einem…
NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Pfizer nach Zahlen…
NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer hat nach einem überraschend starken Schlussquartal 2024 seinen…
NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer blickt verhalten auf das kommende Jahr. 2025 werde…
LUXEMBURG (dpa-AFX) - Der Prozess um SMS zwischen EU-Kommissionspräsidentin Ursula von der Leyen und dem Chef…
NEW YORK (dpa-AFX) - Beim US-Pharmakonzern Pfizer geht es weiter aufwärts. Nach einem abermals unerwartet…
NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Pfizer mit einem…
NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer will bis Ende 2027 rund 1,5 Milliarden US-Dollar…
(Wiederholung vom Vorabend)
NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat die…
NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Pfizer nach Zahlen…
NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat das Kursziel für Pfizer nach Zielvorgaben…